Social Reward and Its Effect on Brain Functions in Psychotherapies for Mid- and Late-Life Depression
Part of paid clinical trials in New York, New York.
- Sponsor
- Weill Medical College of Cornell University
- Study ID
- NCT04487730
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- "Engage & Connect" Psychotherapy — BEHAVIORAL9-weeks of weekly psychotherapy sessions focused on social reward exposure
- Symptom Review and Psychoeducation (SRP) — BEHAVIORAL9-weeks of weekly psychotherapy sessions focused on symptom review and psychoeducation about depression and aging
Study Details
Abnormalities in the Positive Valence System (PVS) are associated with depressive symptoms and reduced behavioral activation in mid- and late-life. This study will investigate the engagement of the PVS during exposure to social rewards, part of a novel streamlined psychotherapy for mid- and late-life depression. Use of computational modeling will enable identification of neuroimaging and behavioral profiles associated with greater treatment response, and may guide future personalization of psychotherapy.
Key Dates
- Start date
- Oct 15, 2020
- Status verified
- May 2025
- Primary completion
- Aug 13, 2024
- Completion
- Aug 19, 2024
Study Design
- Enrollment
- 64 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: "Engage & Connect" Psychotherapy"Engage \& Connect", a modified adapted version of "Engage". Its principal intervention is "social reward exposure" - facilitating engagement in rewarding and meaningful social activities with significant others. In "Engage-S" therapy, individuals with depression work with a therapist to develop "action plans" to pursue rewarding social activities of their choice.
- Active Comparator: Symptom Review and Psychoeducation (SRP)In this intervention, the therapist will review the participant's symptoms and provide literature-based clinical explanations and clarifications about the symptoms, the course, and the causes of depression. In SRP, the therapist reviews the depressed individual's symptoms, and level of information on depression, identifies misconceptions, and guides selection of educational material which could benefit the patient.
Primary Outcome Measure
Change in Resting State fMRI Connectivity of the Positive Valence System [ Time Frame: Baseline, Mid-treatment (Week 5) and Post Treatment (Week 9) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Weill Cornell Medicine | New York | New York | 10065 | - |
Find similar trials in New York, NY
By condition
By specialty
By research site
Related Studies
- Biomarker-guided rTMS for Treatment Resistant DepressionPHASE3 · Recruiting · Weill Medical College of Cornell University · Stanford, California
- Combination of Novel Therapies for CKD Comorbid DepressionPHASE2 · Recruiting · Stony Brook University · Stony Brook, New York
- Aβ Dynamics in LLMDPHASE4 · Recruiting · NYU Langone Health · New York, New York
- Invasive Decoding and Stimulation of Altered Reward Computations in Depression PatientsRecruiting · Icahn School of Medicine at Mount Sinai · New York, New York